Search Results 31-40 of 14140 for SC

  1. Publications - Jay W. Schneider, M.D., Ph.D. - Mayo Clinic

    ... SC, Frantz DE, Olson TM, Steinmetz LM, Carlson DF, Nelson TJ, Wanek Program Preclinical Pipeline. Author Correction: Dysregulated ribonucleoprotein granules ...

  2. Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

    Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple ...

  3. Publications - Scott C. Lester, M.D. - Mayo Clinic

    ... SC, Gamez M, Neben Wittich MA, Price KA, Van Abel KM, Routman DM ... SC, Mutter RW, Park SS, Grams MP. Mini-lattice radiation therapy: A treatment ...

  4. Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    Maurer, Sc.D., M.S., the Lymphoma Biostatistics and Data Science Laboratory at Mayo Clinic uses analytic methods to advance scientific understanding about ...

  5. A Study to Evaluate the Effectiveness, Safety, and Tolerability of Efgartigimod PH20 SC in Patients with Pemphigus - Mayo Clinic

    The primary purpose of this study is to assess the safety of extended treatment and retreatment with efgartigimod PH20 SC in patients with Pemphigus Vulgaris ( ...

  6. Publications - Kaitlin M. Moran, M.D. - Mayo Clinic

    Diaz-Cortes H, Hedges MS, Pacheco-Spann LM, Findley V, Leyva SC, Moran KM, DeStephano CC, Li Z, Colon-Otero G. A feasibility study assessing knowledge ...

  7. Publications - Nevenka Radakovic, M.D. - Mayo Clinic

    DA Wigle, SC Pang, IR Sarda, JD Watson, NN Radakovic, RN Roy, TG Flynn. Acute ethanol treatment modifies the circulating plasma levels of atrial natriuretic ...

  8. Matthew R. Augustine, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... South Carolina home. He completed undergrad as well as medical school at the University of South Carolina in Columbia, SC, prior to coming to the Mayo Clinic.

  9. A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations - Mayo Clinic

    The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...

  10. Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Overview

    Maurer, Sc.D., M.S., the Lymphoma Biostatistics and Data Science Laboratory at Mayo Clinic uses analytic methods to advance scientific understanding about ...